Target intelligence / Profile preview

Chromosome 6 open reading frame 47 (C6orf47)

Target
C6orf47
Molecular classification
MHC class III-associated protein, Trispanin (predicted, based on structure), Transmembrane protein
01

Overview

Chromosome 6 open reading frame 47 (C6orf47) encodes a protein found in the MHC class III locus on 6p21.33 and is predicted to be a trispanin transmembrane protein mainly localized in the endoplasmic reticulum[1][3][5]. It is ubiquitously (but variably) expressed across tissues, with highest RNA levels in the salivary gland and cerebellum, and is overexpressed in colon, bladder, ovary, and pancreas[1]. The function of C6orf47 is poorly characterized; available data suggest it may modulate immune or inflammatory processes, but it is not essential in macrophage lipid metabolism or hypoxic response—expression falls rather than rises under hypoxic conditions[1]. The protein is enriched in leucine, proline, and glycine, and contains three conserved transmembrane domains. Post-translational modifications include phosphorylation (sites: 34, 35, 71, 90), sumoylation (75, 114, 147), and O-linked β-N-acetylglucosamine (site: 60)[1]. The only reported molecular interaction is with fibroblast growth factor receptor 3 (FGFR3), detected at medium confidence through a two-hybrid assay[1]; the relevance of this interaction is unknown. Genetic variants in the C6orf47 locus have been implicated in susceptibility to celiac disease and potentially to non-Hodgkin’s lymphoma and early menopause, but this association is by genomic proximity and interlocus interaction, not by confirmed protein function[3]. There are no pathogenic single nucleotide polymorphisms (SNPs) directly attributable to C6orf47 function[1]. No drugs, mechanisms of action, biomarkers, or safety concerns related to C6orf47 have been reported in scientific literature as of September 2025[1][3][5].

Other names
G4D6S53ENG34Protein G4
02

Mechanism of action

None known; no drug mechanism described for this molecule

03

Biological functions

Protein binding (predicted)Possible modulatory role in immune-mediated and inflammatory processesNot clearly implicated in essential cellular processes; expression seems dispensable under hypoxic conditions in macrophages
04

Disease associations

Immune/inflammatory disease susceptibility (genetic variation in locus associated with celiac disease, rheumatoid arthritis, non-Hodgkin’s lymphoma, early menopause)Not confirmed as a direct disease-causing protein or biomarker; genomic association only
05

Safety considerations

None documented
06

Interacting drugs

None known
07

Biomarkers

No established biomarkers

Beyond the preview

Go deeper on Chromosome 6 open reading frame 47 (C6orf47).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 6 open reading frame 47 (C6orf47).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call